153 related articles for article (PubMed ID: 36057138)
1. Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma.
Alderuccio JP; Reis IM; Habermann TM; Link BK; Thieblemont C; Conconi A; Larson MC; Cascione L; Zhao W; Cerhan JR; Zucca E; Lossos IS
Am J Hematol; 2022 Dec; 97(12):1529-1537. PubMed ID: 36057138
[TBL] [Abstract][Full Text] [Related]
2. A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels.
Kim HD; Cho H; Jeong H; Bang K; Kim S; Lee K; Kang EH; Park JS; Park CS; Huh J; Ryu JS; Lee SW; Yoon DH; Oh SY; Suh C
Br J Haematol; 2021 Apr; 193(2):307-315. PubMed ID: 33216979
[TBL] [Abstract][Full Text] [Related]
3. Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation.
Alderuccio JP; Zhao W; Desai A; Ramdial J; Gallastegui N; Kimble E; de la Fuente MI; Husnain M; Rosenblatt JD; Alencar AJ; Schatz JH; Moskowitz CH; Chapman JR; Vega F; Reis IM; Lossos IS
Am J Hematol; 2019 May; 94(5):585-596. PubMed ID: 30784098
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Marginal Zone Lymphoma International Prognostic Index.
Hong J; Cho J; Ko YH; Kim SJ; Kim WS
Ann Hematol; 2019 Feb; 98(2):457-464. PubMed ID: 30310985
[TBL] [Abstract][Full Text] [Related]
5. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
[TBL] [Abstract][Full Text] [Related]
6. A MALT lymphoma prognostic index.
Thieblemont C; Cascione L; Conconi A; Kiesewetter B; Raderer M; Gaidano G; Martelli M; Laszlo D; Coiffier B; Lopez Guillermo A; Torri V; Cavalli F; Johnson PW; Zucca E
Blood; 2017 Sep; 130(12):1409-1417. PubMed ID: 28720586
[TBL] [Abstract][Full Text] [Related]
7. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of serum immunoglobulin paraprotein in mucosa-associated lymphoid tissue (MALT) lymphoma.
Ren YM; Shang CY; Liang JH; Yin H; Xia Y; Wu JZ; Wang L; Jian-Yong L; Li Y; Xu W
Br J Haematol; 2022 Mar; 196(6):1353-1361. PubMed ID: 34961920
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of absolute monocyte count and lymphocyte to monocyte ratio in mucosa-associated lymphoid tissue (MALT) lymphoma.
Shang CY; Wu JZ; Ren YM; Liang JH; Yin H; Xia Y; Wang L; Li JY; Li Y; Xu W
Ann Hematol; 2023 Feb; 102(2):359-367. PubMed ID: 36624225
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognostic analysis of 90 patients with primary gastro-intestinal marginal zone lymphoma].
Zhao X; Wang L; Zhang S; Wang S; Sun Y; Zhao W
Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):24-8. PubMed ID: 25641141
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
12. [The clinical characteristics and prognostic analysis of gastric mucosa-associated lymphoid tissue lymphoma of 103 cases].
Li XW; Xia B; Guo Q; Jin X; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):805-9. PubMed ID: 23384898
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective analysis of clinical characteristics and prognostic factors for 124 cases of primary gastric lymphomas].
He Y; Wang L; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Cao L; Fan L; Li JY; Xu W
Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):505-510. PubMed ID: 28655094
[No Abstract] [Full Text] [Related]
14. An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.
Alderuccio JP; Arcaini L; Watkins MP; Beaven AW; Shouse G; Epperla N; Spina M; Stefanovic A; Sandoval-Sus J; Torka P; Alpert AB; Olszewski AJ; Kim SH; Hess B; Gaballa S; Ayyappan S; Castillo JJ; Argnani L; Voorhees TJ; Saba R; Chowdhury SM; Vargas F; Reis IM; Kwon D; Alexander JS; Zhao W; Edwards D; Martin P; Cencini E; Kamdar M; Link BK; Logothetis CN; Herrera AF; Friedberg JW; Kahl BS; Luminari S; Zinzani PL; Lossos IS
Blood Adv; 2022 Apr; 6(7):2035-2044. PubMed ID: 35196377
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma.
Saul EE; Alderuccio JP; Reis IM; Zhao W; Iyer SG; Rodriguez G; Desai A; Chapman JR; Tse DT; Markoe AM; Isrow DM; Lossos IS
Am J Hematol; 2023 Jan; 98(1):148-158. PubMed ID: 35560252
[TBL] [Abstract][Full Text] [Related]
16. Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Singh AD; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Br J Haematol; 2016 May; 173(3):404-12. PubMed ID: 26953041
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of international prognostic index, revised international prognostic index, enhanced international prognostic index and Grupo Español de Linfomas/trasplante autólogo de médula ósea-international prognostic index for diffuse large B-cell lymphoma].
Feng YX; Su LP
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):949-954. PubMed ID: 33256307
[No Abstract] [Full Text] [Related]
18. Risk factors analysis and establishment of predictive nomogram of extranodal B-cell lymphoma of mucosal-associated lymphoid tissue.
Hua J; Lia Z; Ma C; Zhang X; Li Q; Duan X; Xiao T; Geng X
Cancer Radiother; 2023 Apr; 27(2):126-135. PubMed ID: 36894407
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma.
Troch M; Wöhrer S; Raderer M
Anticancer Res; 2010 Feb; 30(2):635-9. PubMed ID: 20332482
[TBL] [Abstract][Full Text] [Related]
20. How can we assess and measure prognosis for MALT lymphoma? A review of current findings and strategies.
Kiesewetter B; Raderer M
Expert Rev Hematol; 2021 Apr; 14(4):391-399. PubMed ID: 33764848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
